Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 3284 entries
View as:

AZD2014 and Weekly Paclitaxel in Squamous NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT02403895 Org: User:
Start: 04/15/15 End: 12/29/16 Due: 12/29/17

Risk of Hospitalization for Severe Hypersensitivity (Including Severe Skin Reactions) in Patients With Type 2 Diabetes Exposed to Oral Antidiabetic Treatments

Phase: N/A Priority: Normal
NCT ID: NCT01086319 Org: User:
Start: 08/31/09 End: 12/31/15 Due: 12/31/16

SOLO-Symbicort® in the Treatment of Persistent Asthma in Adolescents & Adults

Phase: N/A Priority: Normal
NCT ID: NCT00238784 Org: User:
Start: 05/31/04 End: 10/31/05 Due: 10/31/06

A Phase I Study of AZD4635 in Japanese Patients With Advanced Solid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT03980821 Org: User:
Start: 07/04/19 End: 09/07/20 Due: 09/07/21

In-practice Evaluation of Atacand 16mg Antihypertensive Effect

Phase: N/A Priority: Normal
NCT ID: NCT00802542 Org: User:
Start: 11/30/08 End: 01/31/09 Due: 01/31/10

A Clinical Study to Investigate the Effects of Dapagliflozin on Heart Work, Heart Nutrient Uptake, and Heart Muscle Efficiency in Type 2 Diabetes Patients

Phase: N/A Priority: Normal
NCT ID: NCT03387683 Org: User:
Start: 02/28/18 End: 03/19/19 Due: 03/19/20

Evaluating Subjective Well-being in Schizophrenic Patients Treated With quetiapineXR® and Other Atypical Antipsychotics

Phase: N/A Priority: Normal
NCT ID: NCT00689325 Org: User:
Start: 04/30/08 End: 01/31/10 Due: 01/31/11

Physician and Patient Perception of Adjustable Maintenance Dosing of Symbicort Turbuhaler

Phase: N/A Priority: Normal
NCT ID: NCT00812682 Org: User:
Start: 09/30/06 End: 08/31/07 Due: 08/31/08

Study to Assess Safety and Efficacy of Ticagrelor (AZD6140) Versus Clopidogrel in Asian/Japanese Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS)

Phase: N/A Priority: Normal
NCT ID: NCT01294462 Org: User:
Start: 02/28/11 End: 07/31/12 Due: 07/31/13

Phase II Iressa & Carbo/Gem in NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT00264498 Org: User:
Start: 10/31/04 End: 06/30/08 Due: 06/30/09

A Study to Identify and Characterise Patients With Chronic Kidney Disease and Proteinuria

Phase: N/A Priority: Normal
NCT ID: NCT05967806 Org: User:
Start: 07/31/23 End: 08/30/24 Due: 08/30/25

Comparing the Efficacy and Safety of Rosuvastatin With Atorvastatin and Simvastatin (SOLAR)

Phase: N/A Priority: Normal
NCT ID: NCT00654173 Org: User:
Start: 06/30/02 End: 09/30/04 Due: 09/30/05

A Study to Investigate the Relative Bioavailability of AZD8630 Following a Device and Formulation Transition in Healthy Participants.

Phase: N/A Priority: Normal
NCT ID: NCT06531811 Org: User:
Start: 08/06/24 End: 10/03/24 Due: 10/03/25

A PD/Safety Study of RDEA3170 in Combination With Febuxostat for Treating Gout or Asymptomatic Hyperuricemia Patients

Phase: N/A Priority: Normal
NCT ID: NCT02317861 Org: User:
Start: 12/31/14 End: 06/30/15 Due: 06/30/16

Proton Pump Inhibitor (PPI) Inappropriate Use and Economic Burden in Chinese Population

Phase: N/A Priority: Normal
NCT ID: NCT03118778 Org: User:
Start: 04/28/17 End: 07/10/17 Due: 07/10/18

Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children & Adolescents With Bipolar I Mania

Phase: N/A Priority: Normal
NCT ID: NCT00090311 Org: User:
Start: 07/31/04 End: 07/31/06 Due: 07/31/07

Effects of 5 Weeks Treatment With Dapagliflozin in Type 2 Diabetes Patients on How the Hormone Insulin Acts on Sugar Uptake in Muscles.

Phase: N/A Priority: Normal
NCT ID: NCT03338855 Org: User:
Start: 03/05/18 End: 11/04/19 Due: 11/04/20

Tolerability/PoP Study in Allergic Rhinitis After Intranasal Administration of AZD8848

Phase: N/A Priority: Normal
NCT ID: NCT00770003 Org: User:
Start: 09/30/08 End: 02/28/10 Due: 02/28/11

ZD1839 (IRESSA™) in Combination With Docetaxel & Cisplatin in Subjects With Metastatic Head & Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00242762 Org: User:
Start: 07/31/03 End: 03/31/06 Due: 03/31/07

A Phase I, Safety Tolerability and Pharmacokinetics of AZD4831 to Treat Cardiovascular Disease

Phase: N/A Priority: Normal
NCT ID: NCT03136991 Org: User:
Start: 05/15/17 End: 11/22/17 Due: 11/22/18

Phase II Gemcitabine + Cisplatin +/- Iressa Bladder CCT

Phase: N/A Priority: Normal
NCT ID: NCT00246974 Org: User:
Start: 05/31/03 End: 12/31/07 Due: 12/31/08

Prevalence of HRR-related Genes Mutations and Prognosis in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients in Real World Setting

Phase: N/A Priority: Normal
NCT ID: NCT04425200 Org: User:
Start: 07/29/20 End: 12/18/20 Due: 12/18/21

Complications of UTI in Patients on Dapagliflozin

Phase: N/A Priority: Normal
NCT ID: NCT02695173 Org: User:
Start: 01/01/17 End: 11/30/20 Due: 11/30/21

The Biological Activity of Cediranib (AZD2171) in Gastro-Intestinal Stromal Tumours(GIST).

Phase: N/A Priority: Normal
NCT ID: NCT00385203 Org: User:
Start: 09/30/06 End: 12/31/09 Due: 12/31/10

Dapagliflozin Effects on Cardiometabolic Outcomes in Patients With an Acute Heart Attack.

Phase: N/A Priority: Normal
NCT ID: NCT04564742 Org: User:
Start: 12/22/20 End: 07/05/23 Due: 07/05/24